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ABSTRACT
The initiation factor 4E (eIF4E) is implicated in most
of the crucial steps of the mRNA life cycle and is
recognized as a pivotal protein in gene regulation.
Many of these roles are mediated by its interaction
with specific proteins generally known as eIF4E-
interacting partners (4E-IPs), such as eIF4G and
4E-BP. To screen for new 4E-IPs, we developed a
novel approach based on structural, in silico and
biochemical analyses. We identified the protein
Angel1, a member of the CCR4 deadenylase
family. Immunoprecipitation experiments provided
evidence that Angel1 is able to interact in vitro and
in vivo with eIF4E. Point mutation variants of Angel1
demonstrated that the interaction of Angel1 with
eIF4E is mediated through a consensus eIF4E-
binding motif. Immunofluorescence and cell frac-
tionation experiments showed that Angel1 is
confined to the endoplasmic reticulum and Golgi ap-
paratus, where it partially co-localizes with eIF4E
and eIF4G, but not with 4E-BP. Furthermore,
manipulating Angel1 levels in living cells had no
effect on global translation rates, suggesting that
the protein has a more specific function. Taken
together, our results illustrate that we developed a
powerful method for identifying new eIF4E partners
and open new perspectives for understanding
eIF4E-specific regulation.
INTRODUCTION
The control of gene expression at the mRNA level is a
complex process that is critical during many physiological
events such as cell cycle, cell growth, differentiation, aging
and cell death. In eukaryotes, the eukaryotic initiation
factor 4E (eIF4E) plays essential roles at several steps of
the mRNA life cycle: translation initiation, nuclear export
[reviewed in (1)], cytoplasmic localization and stability
control (2). The deregulation of eIF4E activities is a key
component in cancer initiation and progression (3,4).
Controlling eIF4E functions is therefore a crucial step in
normal cell proliferation and survival.
During translation initiation, eIF4E binds the cap struc-
ture of mRNA and recruits eIF4G, a large scaffolding
protein that acts as a docking site for several proteins
required for bridging the ribosome and the mRNA (5,6).
The interaction between eIF4E and eIF4G is inhibited in a
competitive manner by the small translational repressor
4E-BP, which shares a consensus eIF4E-binding motif
YxxxxL (where x is a variable amino acid and  is a
hydrophobic residue) with eIF4G (7). The motif-contain-
ing central peptide of 4E-BP (corresponding to residues
51–67 of human 4E-BP1) acts as a molecular mimic of
eIF4G on the convex dorsal surface of eIF4E, forming
an L-shaped structure with an extended chain region
and a short a-helix (8). Nevertheless, the interaction
with eIF4E does not depend only on the central peptide
of 4E-BP as currently thought. In fact, the binding foot-
print of 4E-BP appears to be larger and involves fuzzy
contacts between 4E-BP extremities and the eIF4E
surface (9).
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In the nucleus, eIF4E promotes nucleocytoplasmic
transport of a selected subset of mRNAs. These tran-
scripts, such as cyclin D1 and ODC, are involved in cell
cycle regulation (1,10,11) and carry a speciﬁc 4E-sensitiv-
ity element in their 30UTR (12). Several key regulators of
eIF4E-dependent mRNA export have been identiﬁed,
most of them containing the consensus eIF4E-binding
motif found in 4E-BP or eIF4G (13–15).
Beyond well-known regulators of mRNA export and
translation initiation, some other eIF4E-interacting
partners (4E-IPs) have been discovered (16). These 4E-
IPs, such as Maskin, Bicoid, DDX3, 4E-T, Gemin5 and
GIGYF2, play fundamental roles in cell cycle progression,
metabolism, development, tumor formation and responses
to various stimuli (2,17–21). Consequently, ﬁnding novel
interacting partners of eIF4E would help to understand
cellular mechanisms controlled by eIF4E activity.
In the present study, we used a new approach based on
structural and in silico analyses to ﬁnd new 4E-IPs. Using
a reﬁned eIF4E-binding motif to search databases for po-
tential 4E-IPs, we found a CCR4 family member, Angel1,
which displays an eIF4E-binding motif in its C-terminal
domain.
MATERIALS AND METHODS
Plasmids
Total RNA from 293 cells was prepared using Trizol
puriﬁcation, and reverse transcribed using the Superscript
reverse transcriptase (Invitrogen) according to the manu-
facturer’s instructions. Angel1 cDNA was ampliﬁed
and subcloned in different vectors as indicated in
Supplementary Methods.
Antibodies
The antibodies used for western blotting and immuno-
ﬂuorescence are detailed in Supplementary Methods.
Phylogeny
The original alignment produced by T-Coffee (22)/M-
Coffee (23) on 970 sites was optimized using trimAl (24).
PhyML (25) was used to reconstruct a maximum likeli-
hood (ML) phylogenetic tree (performed with the LG
substitution model (26), 1000 bootstraps and 4 substitu-
tion rate categories). Sequences used are detailed in
Supplementary Methods.
Cell lines
Growth conditions and Angel1-shRNA accession
numbers are detailed in Supplementary Methods.
Immunoprecipitation and m7GTP purification
Details are given in Supplementary Methods.
Expression, production, eIF4E-binding assay
The wild-type and mutant proteins GST-A1 and GST-
A1YA were overexpressed in E. coli [Rosetta (BL21),
Novagen] and puriﬁed on a glutathione sepharose 4B
column (Amersham Pharmacia Biotech) according to the
manufacturer’s instructions. The eIF4E-binding assay and
immunoblot analysis are described in Supplementary
Methods.
Immunofluorescence
Images were collected on a confocal Leica SP5 microscope
using a 40 or 63 oil objective. Cells were prepared as
described in Supplementary Methods.
Cell fractionation
For cell fractionation, the protocol is derived from
Culjkovic-Kraljacic et al. (27). Brieﬂy, around 2.107cells
were washed twice in ice-cold PBS and collected (1000g for
3min). Then cells were resuspended with slow pipetting in
500 ml of hypotonic lysis buffer (10mM Tris pH8.0,
1.5mM MgCl2, 10mM NaCl, 1mM DTT) and vortexed
for 4 s. After centrifugation at 1000g (4C) for 3min,
supernatant (cytoplasmic fraction) was transferred into a
fresh tube. Pellet fraction was washed with hypotonic lysis
buffer and resuspended in 500 ml lysis buffer A (10mM
Tris pH 8.0, 140mM NaCl, 1.5mM MgCl2, 0.5% NP40,
1mM DTT). After centrifugation at 1000g (4C) for
3min, supernatant (microsomal fraction) was transferred
into a fresh tube. Pellet-nuclear fraction was washed once
and resuspended in 500ml of lysis buffer A, transferred to
a 5-ml round-bottom tube and 1/10 volume (50ml) of de-
tergent stock [3.3% (w/v) sodium deoxycholate, 6.6%
(v/v) Tween 40, in DEPC H20] was added under slow
vortexing (this prevents nuclei from clumping) and
incubated on ice for 5min. This suspension was
transferred back to a 1.5ml eppendorf and spun at
1000g at 4C for 3min. Supernatant-postnuclear fraction
was transferred to a fresh tube. The pellet-nuclear fraction
was washed with buffer A and resuspended in 500 ml of
lysis buffer A supplemented with 0.1% SDS and
sonicated.
RESULTS
Angel1, a member of the CCR4 family, acquired an
eIF4E-binding motif in vertebrates
To ﬁnd new eIF4E partners, our ﬁrst approach was to
look for sequences in protein databases that contained
an eIF4E-binding consensus motif, YxxxxL. However,
scanning databases with the webserver Prosite (http://
www.expasy.org/tools/scanprosite) did not produce any
signiﬁcant hits because the probability of ﬁnding this con-
sensus motif randomly in databases is too high. To deﬁne
a more accurate consensus sequence, we performed a
structural analysis using the crystal structures of the
complexes formed between eIF4E and peptides derived
from well-known 4E-IPs: 4E-BP1 and eIF4GI [PDB ID:
1EJ4 and 1EJH, (8)]. We evaluated the change in the 3D
structure after substituting each residue of the peptides
from positions 3 to +6 (annotated from the conserved
tyrosine of the consensus motif) using Turbo-Frodo
software (28). The resulting set of sequences that were
tolerated by the peptides and that could still interact
7784 Nucleic Acids Research, 2013, Vol. 41, No. 16
 at B
IU
S Jussieu on June 6, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
with eIF4E constituted the reﬁned eIF4E-binding
motif matrix (Figure 1A). Scanning the multi-species
UniProtKb/Swiss-Prot database with Prosite revealed
that the reﬁned eIF4E-binding motif was present in 582
sequences (out of 5.105 protein sequences in the database,
data not shown). As expected, we found orthologs of
already known eIF4E-interacting proteins, such as
eIF4Gs or 4E-BPs. Because functionally relevant se-
quences are expected to be conserved throughout evolu-
tion, orthologs that share the reﬁned eIF4E-binding motif
therefore have a greater probability of effectively binding
eIF4E. By pairwise alignment of the 582 sequences
containing the consensus motif, we found 19 groups of
at least three orthologs that shared a coverage rate of
>75% of their lengths and a percentage of identity
>50%. Among these groups, 14 groups had not been pre-
viously characterized as binding partners of eIF4E
(Supplementary Figure S1). To validate the functionality
of each putative eIF4E-binding motif, we fused the human
homolog motif of each group to yellow ﬂuorescent protein
(YFP) as carrier. Six of the 14 fusion proteins were suc-
cessfully produced in rabbit reticulocyte lysate in presence
of 35S methionine before being transferred on an m7GTP
chromatography column pre-loaded with GST-eIF4E. As
expected, YFP fused to the eIF4GI motif was retained on
the eIF4E column (Supplementary Figure S2, lane 11).
Interestingly, the YFP fused to the putative eIF4E-
binding motif taken from a protein identiﬁed as Angel1
was also retained on the eIF4E column (Supplementary
Figure S2, lane 15). Furthermore, the full-length Angel1
protein that we produced in rabbit reticulocyte lysate also
bound to the eIF4E column (Supplementary Figure S3,
lane 6). The Angel1 motif showed high similarity with
the YxxxxL motif in eIF4G and 4E-BP (Figure 1B).
The replacement of the conserved tyrosine with an
alanine in the eIF4G motif prevented binding to eIF4E
(7). Importantly, we also observed that this mutation in
the motif of Angel1 abolished the interaction with eIF4E
(Supplementary Figure S3, lane 8). Never before men-
tioned as a potential 4E-IP, Angel1 has been described
as a member of the CCR4 family due to its conserved
C-terminal endo-exonuclease-phosphatase domain (EEP)
found in CCR4 or Nocturnin proteins (Supplementary
Figure S4) (29,30). The Angel1 locus comes from a dupli-
cation that occurred immediately prior to or early in ver-
tebrate divergence (31), strongly suggesting that, through
genome duplication in vertebrates, the ancestral gene
coding for the Angel protein produced two paralogs
coding for Angel1 and Angel2 (Figure 1C). Interestingly,
we observed that the eIF4E-binding motif is only found in
the C-terminal domain of Angel1 sequences (Figure 1C
and Supplementary Figure S4). Therefore, we assumed
Figure 1. New screening reveals a novel 4E-IP, Angel1, which acquired an eIF4E-binding motif in vertebrates. (A) Combination of structural, in
silico and m7GTP chromatography approaches reveal that Angel1 is a novel eIF4E-interacting protein. See text for details. (B) The putative eIF4E-
binding motifs of Angel1 mouse (m), human (h), chicken (Ga) and Xenopus (Xe) were aligned over several eIF4E-binding proteins. Residues that
were identical or conserved in >75% of the sequences are shaded in black and gray, respectively. The seven last amino acids correspond to the
consensus eIF4E-binding motif YxxxxL. (C) Unrooted phylogenetic tree of Angel-related sequences in 9 species. The presented tree was constructed
using the Maximum Likelihood method (see SI). The brace indicates the sequences that contain the consensus motif (YxxxxL).
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that the eIF4E-binding motif in the Angel1 sequence
appeared simultaneously with or immediately after the
duplication of the ancestral gene angel and has been
conserved throughout the evolution of vertebrates, sug-
gesting that it has functional relevance.
Angel1 is an eIF4E-interacting protein
To analyze the association between cellular Angel1 and
eIF4E, HeLa S3 cell extracts underwent afﬁnity chroma-
tography on m7GTP-sepharose beads (Figure 2A). To
exclude the possibility of RNA-mediated interactions, a
cap-column assay was performed in the presence of
RNase A. In our western blot experiments, Angel1 gener-
ally appeared as a doublet, probably owing to a post-tran-
scriptional process that remains to be identiﬁed. The
endogenous Angel1 protein was retained on the m7GTP
column (Figure 2A, lane 2), as well as the eIF4E partner
eIF4GI. In presence of free m7GTP, Angel1 was eluted
together with eIF4E (Figure 2A, lane 4) and was not
retained on m7-GTP beads (Figure 2A, lane 3). Noting
that Angel1, eIF4GI and 4E-BP1 all have a similar
eIF4E-binding motif, we performed eIF4GI
immunoprecipitation using the same RNase-treated
extract. As expected, we found that PABP and eIF4E
were co-immunoprecipitated with eIF4GI, whereas 4E-
BP1 and Angel1 did not (Figure 2A, lane 7). To further
conﬁrm the existence of the eIF4E/Angel1 complex in cells
and to exclude any possible direct interaction of Angel1
with the cap structure, we performed eIF4E immunopre-
cipitation using the same RNase-treated extract. Angel1
co-precipitated with eIF4E, as well as eIF4GI and 4E-
BP1, while PABP did not (Figure 2B, lane 3). These
three eIF4E-binding partners therefore use the same
binding motif, suggesting that endogenous Angel1 associ-
ates with a complex containing eIF4E through a direct
protein–protein interaction. Altogether, these results
indicate the existence of three mutually exclusive
complexes, eIF4GI/eIF4E, 4E-BP1/eIF4E and Angel1/
eIF4E.
It was then important to assess the function of the po-
tential eIF4E-binding motif YxxxxL in the Angel1
sequence (Figure 2C). In HeLa S3 cells we expressed hem-
agglutinin (HA)-tagged Angel1 and its variant A1YA, in
which the conserved Tyr506 in the putative eIF4E-binding
Figure 2. Angel1 interacts with eIF4E through its eIF4E-binding motif. (A, B) One HeLa S3 cell extract supplemented with RNase A was incubated
with m7GTP beads or used to perform immunoprecipitation with indicated antibodies. Bound proteins were analyzed by western blotting.
(A) Sepharose beads or m7GTP beads (cap-column assay) were incubated directly with Laemmli buffer (lanes 1 and 2). m7GTP beads were incubated
with 200mM free m7GTP; eluates (lane 4) and residual proteins attached to m7GTP beads (lane 3) were resolved on SDS-PAGE.
Immunoprecipitations with anti-eIF4GI (lane 7) or isotype control antibody (anti-GFP, lane 6) contain immunoglobulin (IgG). Total lysate is
presented in lane 5. (B) Immunoprecipitation using anti-eIF4E (lane 3) or isotype control antibody (anti-HA, lane 2) were performed with the same
total lysate (lane 1) as in A. (C) Angel1 interacts with eIF4E through the conserved eIF4E-binding sequence. HeLa S3 cells were mock-transfected, or
transfected with HA-A1 or HA-A1YA expressing vectors. Cell lysates were subjected to HA-immunoprecipitation. Whole lysates (input) and
immnoprecipitates (IP HA) were analyzed by immunoblotting. (D) Angel1 competes with eIF4GI for binding to eIF4E in vitro. HeLa S3 cell
lysates were supplemented with wild-type (lane 2) or mutant Angel1 (lane 3) GST-fusion protein (1 mg each) and incubated with m7GTP beads. 1/50
of total extracts (Input) and proteins bound to m7GTP beads (cap-column) were analyzed by western blot. The ability of recombinant wild-type or
mutant Angel1 to bind endogenous eIF4E and displace eIF4GI was monitored using an anti-GST antibody.
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site was replaced by an alanine. We ﬁrst checked by
western blot that the HA-A1 and HA-A1YA proteins
were similarly expressed following transfection of HeLa
S3 cells (Figure 2C, Input, lanes 2 and 3). HA-A1 and
HA-A1YA expressed in cells had two major forms with
sizes of 80 and 74 kDa (Figure 2C, lanes 2, 3), suggesting
again that Angel1 is post-translationally modiﬁed.
Because the exogenous Angel1 protein is HA-tagged at
the N-terminus, one possibility is a C-terminal truncation
of the protein. Performing anti-HA immunoprecipitation,
HA-A1 brought down eIF4E (Figure 2C, lane 2), while
HA-A1YA did not (Figure 2C, lane 3), demonstrating
that the eIF4E-binding site of Angel1 is required for its
association with eIF4E.
Angel1 and eIF4GI share the same consensus eIF4E-
binding motif; we therefore expected that Angel1 was able
to displace the eIF4G/eIF4E interaction. GST-A1 and
GST-A1YA proteins were produced in bacteria and
puriﬁed on glutathione sepharose. Recombinant proteins
were incubated with HeLa cell extracts, and endogenous
eIF4E was puriﬁed on an m7GTP column. Proteins
associated with eIF4E were analyzed by western blotting
(Figure 2D). GST-A1 associated with endogenous eIF4E,
but GST-A1YA did so only weakly (Figure 2D, compare
lanes 2 and 3). In particular, binding of GST-A1 to en-
dogenous eIF4E impaired the interaction between eIF4E
and endogenous eIF4GI (Figure 2D, compare lanes 2 and
3). These results demonstrate that, in cell extracts, recom-
binant Angel1 competes with eIF4GI for binding to
eIF4E.
We next addressed whether Angel1 could also compete
in vivo with eIF4G. HA-A1 and HA-A1YA were ex-
pressed in HeLa S3 cells and eIF4GI bound to eIF4E
was monitored using a cap-column assay (Figure 3A).
As expected, only HA-A1 bound efﬁciently to eIF4E,
while HA-A1 and HA-A1YA were expressed at similar
levels. However, HA-A1 did not alter the in vivo eIF4GI
interaction with eIF4E (Figure 3A, compare lanes 1 and 2
with lanes 4 and 5).
Because eIF4E availability for eIF4G appears to be in-
dependent of Angel1, we hypothesized that manipulating
Angel1 levels in living cells would have only a marginal
effect on global translation rates. To test this hypothesis,
Angel1 was overexpressed and protein synthesis was
measured by 35S-methionine incorporation (Figure 3B).
As expected, Angel1 overexpression did not affect the
global protein synthesis rate. It is interesting to note that
the overexpressed protein is localized in the perinuclear
area (Figure 3C). Furthermore, polysome proﬁles in
Sh-Angel1-expressing cell lines were not affected
(Supplementary Figure S5C).
It is well known that hypophosphorylated 4E-BP1
competes with eIF4GI for a common binding site
on eIF4E (32); we therefore explored whether
hypophosphorylated 4E-BP1 could disrupt the Angel1–
eIF4E interaction in living cells (Figure 4A). To induce
in vivo 4E-BP1 hypophosphorylation, HeLa S3 cells were
treated with PP242 (Figure 4A, lanes 2, 4, 8), an active-site
mTOR inhibitor (33). Proteins from untreated and PP242-
treated HeLa S3 cell extracts were immunoprecipitated
using an anti-eIF4E antibody (Figure 4A, respectively
lanes 3 and 4) or puriﬁed on a cap-column (Figure 4A,
lanes 7 and 8). As expected, the amount of 4E-BP1 bound
to eIF4E increased signiﬁcantly after PP242 treatment
(Figure 4A, compare lanes 3 and 4; lanes 7 and 8,
bottom panels) while the quantity of eIF4GI bound to
eIF4E decreased (Figure 4A, top panels). Strikingly, the
Angel1 association with eIF4E was not affected when cells
were treated with PP242. Taken together these data dem-
onstrate that the formation of the Angel1/eIF4E complex
is independent of the mTOR signaling pathway and its
downstream target 4E-BP.
Therefore, our results demonstrate that Angel1 associ-
ates in vivo with eIF4E. However, eIF4E availability for
eIF4G or 4E-BP—and consequently the global protein
synthesis rate—are independent of this new eIF4E
partner.
Angel1 is predominantly found in the cytoplasmic
perinuclear area and co-localizes with eIF4E in
small particles
Because eIF4E availability for eIF4G or 4E-BP is inde-
pendent of Angel1, we then explored whether Angel1
targets a speciﬁc pool of eIF4E. The cellular localizations
of Angel1 and eIF4E proteins were examined (Figure 5).
Indirect immunoﬂuorescence with anti-Angel1 antibodies
showed that Angel1 predominantly localizes in the cyto-
plasmic perinuclear area of HeLa S3 cells (Figure 5A).
These results are in agreement with the localization of
the overexpressed Angel1 protein (Figure 3C). As
expected, no green ﬂuorescence staining was seen after
shutting down the expression of Angel1 with shRNA
(Figure 5A, Supplementary Figure S5A and B). Double-
labeling experiments using the anti-Angel1 and the
anti-eIF4E antibodies were performed (Figure 5B). As
previously demonstrated (34), eIF4E is also localized pre-
dominantly in the perinuclear area. However, strict co-lo-
calization of the two proteins was restricted to small
particles as revealed by higher resolution examination
(Figure 5B, lower right panel), thus conﬁrming the idea
that Angel1 targets only a fraction of eIF4E in the cell.
Furthermore, the extinction of Angel1 expression did not
affect the cellular localization of eIF4E (Supplementary
Figure S5B), suggesting that eIF4E localization is inde-
pendent of Angel1.
Angel1 is mainly distributed in the endoplasmic reticulum
and Golgi apparatus
To gain insight into the perinuclear localization of Angel1,
we then investigated whether it is distributed in organelles
that are usually found at the periphery of the nucleus.
Angel1 localization was compared with that of Calnexin,
an endoplasmic reticulum (ER) transmembrane protein
acting as a chaperone in protein folding (35) and interact-
ing directly with ribosomes (36). A double-label immuno-
ﬂuorescence experiment was performed with anti-Calnexin
and anti-Angel1 antibodies (Figure 6A). Angel1 co-
localized primarily with the ER in these cells. A double-
label immunoﬂuorescence experiment was then performed
with the anti-Angel1 and an anti-GM130 antibody, target-
ing a constituent of the cis-Golgi matrix facilitating
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ER-Golgi transport (37). As shown in Figure 6B, the
higher ﬂuorescence intensity for Angel1 and GM130
were signiﬁcantly polarized on the same side of the
nucleus and showed an incomplete overlap, with Angel1
displaying a wider overall distribution than the Golgi ap-
paratus. We then addressed the speciﬁc localization of
Angel1 by subcellular fractionation (Figure 6C). Western
blotting was used to probe for Calnexin (ER marker),
GM130 (Golgi Marker), Histone H1 (nucleus marker),
eIF4E, eIF4GI, 4E-BP1 and Angel1 (Figure 6C). Angel1
was mostly present in the perinuclear (P) and microsomal
(M) fractions, containing the ER and Golgi markers. We
also found traces of Angel1 in cytosolic and nuclear frac-
tions (C & N). eIF4E and eIF4GI were enriched in the
cytoplasm and microsomal fractions (C & M), whereas
4E-BP1 was primarily located in the cytosol (C). Thus,
Angel1 appears primarily associated with the ER.
DISCUSSION
We identiﬁed Angel1 as a novel 4E-IP with a new strategy
based on a structural and in silico analysis using phyl-
ogeny as a selective ﬁlter. We demonstrated the physio-
logical interaction between Angel1 and eIF4E (Figure 2).
Given that the interaction occurs through an eIF4E-
binding motif similar to those found in most 4E-IPs,
and that recombinant Angel1 competes with eIF4G to
bind to eIF4E (Figure 2D), we infer that Angel1 binds
to the interaction site located on the dorsal surface of
eIF4E. The eIF4E-binding motif of Angel1 appears in
the vertebrate lineage by the acquisition of an extra
exon of 111 nucleotides encoding 37 amino acids
(Supplementary Figure S6). We did not ﬁnd the origin
of this exon, suggesting that it appeared by gene transfer
from a non-sequenced organism or by generation of a
completely new sequence in the angel1 gene.
We demonstrated that the binding of Angel1 to eIF4E is
not sensitive to the mTOR pathway and is not affected by
an increase in the eIF4E/4E-BP association (Figure 4),
suggesting that 4E-BP and Angel1 do not interact with
the same fraction of eIF4E in cells. Interestingly, cell frac-
tionation showed that Angel1 and 4E-BP are not
co-distributed in cells, with 4E-BP co-fractionating with
cytosolic fractions while Angel1 co-distributes with the
ER and Golgi elements (Figure 6C). Consequently, the
Figure 3. Overexpressed Angel1 neither competes with eIF4G nor affects general translation activity. HeLa S3 cells were mock-transfected, or
transfected with HA-A1 or HA-A1YA expressing vectors. (A) Transfected cells were lysed and used for m7GTP chromatography and analyzed by
immunoblotting. The membrane incubated with the anti-HA tag was then reprobed with the anti-Angel1 antibody. (B) In parallel, 24 h after
transfection, cells were incubated with 35S-methionine and treated as described in ref. 56 using TCA to precipitate labeled proteins. 35S-methionine
incorporation into proteins is expressed as a percentage of the mock-transfected control (n=5). (C) Localization of HA-Angel1 was determined by
indirect immunoﬂuorescence with anti-HA and anti-Rat IgG-TRITC antibodies. Nuclei were stained with 1mg/ml of Hoescht.
Figure 4. Angel1–eIF4E interaction is not sensitive to mTOR inhib-
ition. HeLa S3 cells were treated with or without 2.5 mM PP242
(mTOR inhibitor) for 1 h. Cell extracts were incubated with m7GTP
beads (cap-column, lanes 7 and 8), a-eIF4E-sepharose beads (lanes 3
and 4) or sepharose beads alone (lanes 5 and 6), as described in
Figure 2A and B. Whole cell lysates (lanes 1 and 2) and bound
proteins were analyzed by immunoblotting.
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association between Angel1 and eIF4E seems to occur in a
4E-BP-free cellular area, providing an explanation for the
binding of Angel1 to eIF4E following PP242 treatment
(Figure 4).
In the cell fractionation experiment, Angel1 co-
distributed with a pool of eIF4GI and eIF4E
(Figure 6C). Distribution of eIF4GI and eIF4E in micro-
somal and perinuclear fractions is in accordance with
studies by Willet et al. (34,38), which show that a sub-
fraction of initiation factors is associated with cellular
structures and has perinuclear localization in ﬁbroblasts
(34). More importantly, a fraction of eIF4E and eIF4GI is
associated with the Golgi apparatus, and some of these
factors co-localize with active sites of translation, while
4E-BP is localized in the cytosol (38). Our immunoﬂuor-
escence experiments revealed that Angel1 has a speciﬁc
perinuclear localization, strongly associated with the ER
and the Golgi apparatus (Figures 5 and 6), thereby
corroborating the distribution of Angel1 in cell fraction-
ation (Figure 6C). Moreover, Angel1 partially co-localized
with eIF4E in speciﬁc particles in the perinuclear area
(Figure 5B), suggesting that Angel1 interacts with a
speciﬁc pool of eIF4E associated with the ER or the
Golgi apparatus. Using known amounts of recombinant
GST-Angel1 and GST-eIF4E (39) proteins, we determined
that the ratio of eIF4E:Angel1 in HeLa S3 cell extracts is
5:1 (data not shown). This value is much higher than 1:1
ratio observed for eIF4E:4E-BP (40) and the 2:1 ratio
observed for eIF4E:eIF4GI (41). We therefore conclude
that Angel1 is not broadly distributed in the cell, but
rather is concentrated in the endoplasmic reticulum and/
or Golgi apparatus.
In eukaryotic cells, mRNAs are not homoge-
neously distributed in the cytoplasm. High-throughput
technologies have recently uncovered that subcellular tar-
geting of mRNAs is a widespread phenomenon (42,43).
Interestingly, a substantial proportion of mRNAs are
localized in the ER independently of the classical signal
sequence/SRP pathway (44). Our polysome analysis of
HeLa S3 cells showed that Angel1 is not associated with
polysomes (Supplementary Figure S7B) and may be
involved in large RNP complexes. Co-localization of
eIF4E with Angel1 in perinuclear particles, as well as
the co-staining of Angel1 with the Golgi apparatus and
the ER, suggests that Angel1 may be involved in the regu-
lation of speciﬁc eIF4E-bound mRNAs localized in the
ER and Golgi compartments. Because these mRNAs
may represent a small proportion of the total cellular
mRNAs, it is not surprising that Angel1 overexpression
or knockdown did not drastically affect general transla-
tion activity (Figure 3 and Supplementary Figure S5C).
In accordance with the localization of Angel1,
overexpressed HA-Angel1 also displayed a perinuclear
pattern (Figure 3C).
Notably, we showed that, by adding recombinant
Angel1 to a cell extract, Angel1 is able to compete
in vitro with eIF4G for binding with eIF4E (Figure 2D).
However we failed to observe this competition in vivo after
HA-Angel1 overexpression (Figure 3). This discrepancy
may be due to different Angel1:eIF4G ratios to eIF4E.
In that case, Angel1 may compete with eIF4G only in
cellular areas where this ratio is high enough to repress
translation of speciﬁc localized mRNAs. Nevertheless, we
cannot exclude the possibility that Angel1/eIF4E and
eIF4G/eIF4E complexes may be independent and co-
exist in the cell. In that case, Angel1/eIF4E may serve a
more speciﬁc—still unknown—function related to the ER.
CCR4 proteins belong to the endonuclease-exonucle-
ase-phosphatase (EEP) group and display a Mg2+-depend-
ent 30-50 deadenylase activity that functions in the ﬁrst step
of the degradation of poly(A) mRNAs (45). The
C-terminal domain of Angel1 displays signiﬁcant
homology with the conserved EEP domain carrying the
Figure 5. Angel1 co-localizes speciﬁcally with eIF4E in small peri-
nuclear granules. (A) Immunoﬂuorescence staining was performed
with the anti-Angel1 antibody (Sigma) and an Alexa 488-conjugated
anti-rabbit secondary antibody (green) on HeLa S3 cells or sh-Angel1
expressing cell lines. Nuclei were stained with 1 mg/ml of Hoescht. The
subcellular localization of Angel1 was visualized using confocal micros-
copy. (B) Immunoﬂuorescence staining was performed on HeLa S3
cells with the anti-Angel1 and Alexa 488-conjugated anti-rabbit
(green) and an anti-eIF4E-speciﬁc polyclonal Alexa 555-conjugated
antibody (red). Co-localization of Angel1 and eIF4E appears in
yellow and is indicated by white arrows.
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deadenylase function of CCR4 (30,46). Although exo-
nuclease 30-50 activity has been shown in Angel orthologs
in yeast (47,48), we failed to detect any speciﬁc nuclease
activity of the recombinant GST-Angel1 protein, consist-
ent with previous observation for afﬁnity-puriﬁed Angel1
from human cells (42). However, Angel1 has been shown
to interact with CAF1B (49), which has deadenylase
activity (50), suggesting that Angel1 may recruit CAF1B
in eIF4E complexes. In our model, Angel1 would have
two functions for regulating speciﬁc mRNAs and
bringing them into translationally silenced particles.
Impeding eIF4G–eIF4E interaction locally may inhibit
translation, and CAF1B recruitment would lead to
deadenylation of the mRNA. Speciﬁc mRNAs, following
export from the nuclear pore complex, reside in associ-
ation with the ER membrane in translationally silenced
mRNPs, sequestered by Angel1 that interacts with
eIF4E. Taken together, our results provide clear
evidence that Angel1 is a new interacting partner of
eIF4E and opens new perspectives for understanding the
regulation of compartmentalized protein expression and
eIF4E functions.
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